Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NXP Semiconductors N.V. Common Stock (NXPI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

NXP Semiconductors N.V. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

NXP Semiconductors N.V. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? NXP Semiconductors N.V. Common Stock trades at $217.7 (market cap $55.69B), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 31.6× Vir Biotechnology Inc. Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.84% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 5 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NXPIVIR
Market Cap
$55.69B$1.76B
Volume
4,397,7712,764,948
Sector
TechnologyHealth
52-Week High
$332.67$11.78
52-Week Low
$184.19$5.12
Typical Hold Time
5 Days0 Days
Enterprise Value
$63.80B$1.32B
Dividend Yield
1.84%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NXP Semiconductors N.V. Common Stock

NXP Semiconductors (NXPI) trades at $226.32, up 0.49% with a bearish technical signal despite strong fundamentals. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue grew to $12.27B in 2025 with a robust 22.56% net margin, while analysts maintain a 65% buy rating with a $282.88 consensus target. Recent news highlights executive stock sales and focus on physical AI leadership.

NXPI offers growth potential driven by earnings beats and strategic positioning in semiconductors, but faces near-term technical pressure and competitive risks. The stock trades below analyst targets, suggesting upside if fundamentals hold. Key risks include market volatility and execution challenges in a cyclical industry.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NXPI

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About NXP Semiconductors N.V. Common Stock

NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.

Read more on NXPI →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →